MedPath

GULF PHARMACEUTICAL INDUSTRIES

GULF PHARMACEUTICAL INDUSTRIES logo
🇪🇬Egypt
Ownership
Public
Established
1980-01-01
Employees
1K
Market Cap
$295.3M
Website
http://www.julphar.net

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal

Phase 1
Completed
Conditions
Diabetes Mellitus
Interventions
Drug: Julphar Insulin N (human isophane insulin)
Drug: Huminsulin® Basal (NPH, human isophane insulin)
First Posted Date
2015-12-18
Last Posted Date
2020-07-02
Lead Sponsor
Julphar Gulf Pharmaceutical Industries
Target Recruit Count
85
Registration Number
NCT02634528
Locations
🇩🇪

Profil Neuss GmbH, Neuss, Germany

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal

Phase 1
Completed
Conditions
Diabetes Mellitus
Interventions
Drug: Huminsulin® Normal (soluble human insulin, reference)
Drug: Julphar Insulin R (soluble human insulin, biosimilar)
First Posted Date
2015-12-18
Last Posted Date
2015-12-24
Lead Sponsor
Julphar Gulf Pharmaceutical Industries
Target Recruit Count
26
Registration Number
NCT02634515
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III

Phase 1
Completed
Conditions
Diabetes Mellitus
Interventions
Drug: human biphasic insulin
Drug: human biphasic insulin, reference
First Posted Date
2015-12-16
Last Posted Date
2016-08-02
Lead Sponsor
Julphar Gulf Pharmaceutical Industries
Target Recruit Count
73
Registration Number
NCT02631928
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.